DOCS Doximity Inc
Company Analysis
Latest News
🟢 Doximity is trading 6% up today amid a broad U.S. market rally
Doximity is trading at $34.43, up 5.61%, in line with a broad U.S. market rally as election uncertainty eased and risk appetite improved. - Major indexes were...
Doximity Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Doximity is expected to report Q3 2026 revenue of $170.84 million and GAAP EPS of $0.19, with the current stock price of $32.87 trading slightly above the...
🔴 Doximity is trading 4.62% down in pre-market with no clear company-specific catalyst
Doximity is trading 4.62% lower at $31.35 in pre-market, with no fresh company-specific catalyst clearly explaining the decline. - Latest company news...
Doximity launches 'DoseCheck' to improve safety of AI-generated drug recommendations
Doximity launched DoseCheck. This new safety feature integrates into its Doximity Ask clinical decision support tool. DoseCheck aims to reduce medication...
🔴 Doximity is trading 5.5% down in pre-market with no clear catalyst identified
Doximity is trading 5.5% down at $31.27 after closing at $33.08 on October 26; reporting does not establish a clear direct catalyst for the pre-market...
OpenEvidence Challenges Doximity With Reported Use by Nearly Two-Thirds of U.S. Doctors
Multiple reports say nearly two-thirds of U.S. physicians use OpenEvidence, a private AI-powered medical search engine. [2, 21, 22] The company has reached a...
🟢 Doximity is trading 5% up after announcing an UpToDate partnership
Doximity is trading at $33.04, up 5.06%, after announcing a Wolters Kluwer Health partnership integrating UpToDate resources into its platform, including...
Doximity Adds UpToDate to Platform, Including AI-Powered Ask
Doximity announced a partnership with Wolters Kluwer Health, a global provider of clinical technology and evidence-based solutions. The partnership will...
🟢 Doximity is trading 4.04% up with no clear catalyst identified
Doximity is trading at $31.13, up +4.04%, with no clear company-specific catalyst identified for October 15, 2026. - The Aledade Clinical AI integration...
🟢 Doximity is trading 4.7% up with no clear catalyst identified
Doximity is trading at $28.99, up 4.69%, with no clear company-specific catalyst identified for the October 8 gain. - Recent coverage mainly concerns...
🟢 Doximity is trading 5% up with no clear catalyst identified
Doximity is trading at $27.86, up 5.03%, with no clear company-specific catalyst identified for the September 30, 2026 move. - Evercore ISI maintained an In...
🟢 Doximity is trading 7.5% up in pre-market as catalyst remains unclear
Doximity is trading at $28.50, up 7.47% in pre-market, with no clear catalyst identified. - No company announcement or major event found clearly explains the...
Doximity Seeks Sanctions Against OpenEvidence in Ongoing Lawsuit
Doximity filed for sanctions against OpenEvidence in their ongoing lawsuit. It asked the court to dismiss OpenEvidence's claims. Doximity also requested a...
🔴 Doximity is trading 5% down in pre-market with no clear company-specific catalyst
Doximity is trading at $25.03, down 5.01% in pre-market on September 28, with no newly reported company-specific catalyst identified. - The latest company...
Doximity Faces Class Action Lawsuit Over Alleged Misleading Statements
Robbins LLP and Bernstein Litowitz Berger & Grossmann LLP, along with other law firms, filed a class-action lawsuit against Doximity Inc. The suit represents...
🟢 Doximity is trading 4.3% up in after-hours trading with no confirmed company-specific catalyst
Doximity is trading 4.3% up at $26.90 in after-hours trading; no confirmed earnings release, major announcement, or late-breaking company news explaining the...
🟢 Doximity is trading 4.1% up today as U.S. markets rally after August inflation data
Doximity is trading 4.1% up at $25.72 after broad U.S. equity markets moved higher following August inflation data. - The S&P 500, Nasdaq Composite, and Dow...
🔴 Doximity is trading 4.52% down today after Freedom Capital cut rating to Hold
Doximity is trading 4.52% down at $25.16 after Freedom Capital downgraded the stock from Buy to Hold on September 8, 2026, citing margin concerns and limited...
🔴 Doximity is trading 5% down in pre-market — catalyst remains unclear
Doximity is trading 4.89% down now at $25.06, after declining from the September 7 close of $26.35; the catalyst remains unclear. • No credible...
🟢 Doximity is trading 4.1% up today on software-sector momentum after Nvidia and Salesforce results
Doximity is trading 4.1% up now at $26.64, extending its August 27 close of $25.59, as software shares rally after Nvidia’s results and Salesforce’s earnings...